2-105361446-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001318895.3(FHL2):​c.689-12C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 1,606,806 control chromosomes in the GnomAD database, including 27,056 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4349 hom., cov: 33)
Exomes 𝑓: 0.16 ( 22707 hom. )

Consequence

FHL2
NM_001318895.3 intron

Scores

2
Splicing: ADA: 0.0005900
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.861

Publications

6 publications found
Variant links:
Genes affected
FHL2 (HGNC:3703): (four and a half LIM domains 2) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2016]
C2orf49 (HGNC:28772): (chromosome 2 open reading frame 49) Predicted to be involved in embryonic morphogenesis. Located in nucleus. Part of tRNA-splicing ligase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 2-105361446-G-C is Benign according to our data. Variant chr2-105361446-G-C is described in ClinVar as [Benign]. Clinvar id is 48329.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.525 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHL2NM_001318895.3 linkc.689-12C>G intron_variant Intron 6 of 6 ENST00000530340.6 NP_001305824.1 Q14192-1Q6I9R8Q2XQU9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHL2ENST00000530340.6 linkc.689-12C>G intron_variant Intron 6 of 6 1 NM_001318895.3 ENSP00000433567.2 Q14192-1

Frequencies

GnomAD3 genomes
AF:
0.213
AC:
32315
AN:
152008
Hom.:
4347
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.333
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.129
Gnomad EAS
AF:
0.542
Gnomad SAS
AF:
0.200
Gnomad FIN
AF:
0.136
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.205
GnomAD2 exomes
AF:
0.210
AC:
51251
AN:
244478
AF XY:
0.199
show subpopulations
Gnomad AFR exome
AF:
0.347
Gnomad AMR exome
AF:
0.284
Gnomad ASJ exome
AF:
0.133
Gnomad EAS exome
AF:
0.564
Gnomad FIN exome
AF:
0.137
Gnomad NFE exome
AF:
0.133
Gnomad OTH exome
AF:
0.185
GnomAD4 exome
AF:
0.157
AC:
228479
AN:
1454680
Hom.:
22707
Cov.:
31
AF XY:
0.156
AC XY:
113016
AN XY:
723240
show subpopulations
African (AFR)
AF:
0.336
AC:
11159
AN:
33200
American (AMR)
AF:
0.273
AC:
11974
AN:
43828
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
3534
AN:
25910
East Asian (EAS)
AF:
0.526
AC:
20802
AN:
39544
South Asian (SAS)
AF:
0.196
AC:
16737
AN:
85270
European-Finnish (FIN)
AF:
0.140
AC:
7484
AN:
53330
Middle Eastern (MID)
AF:
0.135
AC:
771
AN:
5720
European-Non Finnish (NFE)
AF:
0.131
AC:
145054
AN:
1107752
Other (OTH)
AF:
0.182
AC:
10964
AN:
60126
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
7780
15559
23339
31118
38898
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5578
11156
16734
22312
27890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.213
AC:
32349
AN:
152126
Hom.:
4349
Cov.:
33
AF XY:
0.215
AC XY:
15996
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.333
AC:
13815
AN:
41492
American (AMR)
AF:
0.216
AC:
3295
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
449
AN:
3472
East Asian (EAS)
AF:
0.541
AC:
2799
AN:
5170
South Asian (SAS)
AF:
0.199
AC:
959
AN:
4826
European-Finnish (FIN)
AF:
0.136
AC:
1436
AN:
10568
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.133
AC:
9036
AN:
68012
Other (OTH)
AF:
0.211
AC:
446
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1227
2454
3680
4907
6134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.171
Hom.:
502
Bravo
AF:
0.229
Asia WGS
AF:
0.363
AC:
1263
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 16, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

689-12C>G in intron 5 of FHL2: This variant is not expected to have clinical sig nificance because it is not located within the splice consensus sequence and has been identified in 33% (1242/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS; dbSNP rs2244182). -

Primary dilated cardiomyopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
12
DANN
Benign
0.66
PhyloP100
0.86
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00059
dbscSNV1_RF
Benign
0.062
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2244182; hg19: chr2-105977903; COSMIC: COSV59078969; COSMIC: COSV59078969; API